Clinical Trial Update: Proof of Concept Study on BP1.4979 Effect on Primary Premature Ejaculation [Phase 2]

View source ↗

Summary

Phase 2 proof-of-concept trial investigating BP1.4979 for primary premature ejaculation is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Premature Ejaculation

Drugs mentioned

• BP1.4979

Snippet

Sponsor: Bioprojet | Conditions: Premature (Early) Ejaculation | Phase 2 | Status: RECRUITING